These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28763304)

  • 1. Chronic inflammatory demyelinating polyneuropathy.
    Lewis RA
    Curr Opin Neurol; 2017 Oct; 30(5):508-512. PubMed ID: 28763304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
    Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
    Kazmi MA; Mahdi-Rogers M; Sanvito L
    Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Ruts L
    Curr Opin Neurol; 2004 Oct; 17(5):607-13. PubMed ID: 15367865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review.
    Kohle F; Kuwabara S; Lehmann HC
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):473-478. PubMed ID: 33563801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
    J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
    Stino AM; Naddaf E; Dyck PJ; Dyck PJB
    Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
    Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
    Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kaulen B; Hagemann L; Lehmann HC
    Fortschr Neurol Psychiatr; 2024 Jun; 92(6):247-258. PubMed ID: 38876143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
    Oaklander AL; Gimigliano F
    NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.